
Danaher Corporation DHR
€ 149.27
-2.12%
Geschäftsbericht 2025
hinzugefügt 24.02.2026
Danaher Corporation DSO 2011-2026 | DHR
DSO Jährlich Danaher Corporation
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 55.3 | 57 | 61.3 | 59.8 | 63.8 | 59.3 | 65 | 64 | 70.1 | 68.9 | 70.4 | 66.6 | 65.9 | 65.3 | 69.2 |
Alle Zahlen in USD-Währung
Indikatorenreichweite aus Jahresberichten
| Höchstwert | Mindestwert | Durchschnitt |
|---|---|---|
| 70.4 | 55.3 | 64.1 |
DSO Vierteljährlich Danaher Corporation
| 2025-Q1 | 2024-Q4 | 2024-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 56 | - | - | - | - | 52.6 | 53.6 | - | 52.4 | 55.2 | 57.7 | - | 62.7 | 69.7 | 76 | 59.8 | 66.5 | 65.5 | 67.3 | 55.5 | 65.6 | 63.9 | 68.1 | 63.2 | 71 | 71.2 | 72.8 | 63.4 | 70.4 | 68.5 | 71.8 | 63 | 90.3 | 72.9 | 72 | 60.2 | 68.6 | 66.8 | 67.8 | 61 | 67.5 | 66.5 | 69 | 59.9 | 67.5 | 65.5 | 66.8 | 59 | 62.6 | 76.5 | - |
Alle Zahlen in USD-Währung
Indikatorspanne aus vierteljährlicher Berichterstattung
| Höchstwert | Mindestwert | Durchschnitt |
|---|---|---|
| 90.3 | 52.4 | 65.5 |
DSO anderer Aktien in der Diagnostik & Forschung
| Name | DSO | Preis | % 24h | Marktkapitalisierung | Land | |
|---|---|---|---|---|---|---|
|
Burning Rock Biotech Limited
BNR
|
31.7 | $ 17.1 | 0.56 % | $ 181 M | ||
|
CareDx, Inc
CDNA
|
51.5 | $ 21.5 | 3.32 % | $ 1.15 B | ||
|
Centogene N.V.
CNTG
|
145 | - | -6.23 % | $ 30.6 M | ||
|
Accelerate Diagnostics
AXDX
|
291 | - | -61.36 % | $ 2.46 M | ||
|
Agilent Technologies
A
|
63.8 | $ 114.52 | -0.86 % | $ 34.8 B | ||
|
Co-Diagnostics
CODX
|
94.7 | $ 1.55 | - | $ 2.06 M | ||
|
Castle Biosciences
CSTL
|
49.2 | $ 24.81 | 1.31 % | $ 689 M | ||
|
Akumin
AKU
|
57.4 | - | -17.87 % | $ 25.9 M | ||
|
Biocept
BIOC
|
112 | - | -13.05 % | $ 7.29 M | ||
|
Aspira Women's Health
AWH
|
1.17 K | - | -6.19 % | $ 10.5 M | ||
|
Fulgent Genetics
FLGT
|
77.4 | $ 14.13 | -6.98 % | $ 427 M | ||
|
ICON Public Limited Company
ICLR
|
68.5 | $ 112.85 | -4.63 % | $ 9.31 B | ||
|
Chembio Diagnostics
CEMI
|
66.3 | - | 0.22 % | $ 16.8 M | ||
|
Oxford Immunotec Global PLC
OXFD
|
90.8 | - | - | $ 562 M | ||
|
Heska Corporation
HSKA
|
40.8 | - | - | $ 1.31 B | ||
|
HTG Molecular Diagnostics
HTGM
|
101 | - | -20.0 % | $ 1.06 M | ||
|
Illumina
ILMN
|
61.3 | $ 135.78 | 7.13 % | $ 21.6 B | ||
|
Lantheus Holdings
LNTH
|
80.5 | $ 85.5 | 1.04 % | $ 5.77 B | ||
|
DermTech
DMTK
|
80.6 | - | -11.32 % | $ 2.94 M | ||
|
Global Cord Blood Corporation
CO
|
112 | - | - | $ 399 M | ||
|
Fluidigm Corporation
FLDM
|
67.2 | - | 1.08 % | $ 308 M | ||
|
Genetic Technologies Limited
GENE
|
11.7 K | - | - | $ 7.1 B | ||
|
Genetron Holdings Limited
GTH
|
122 | - | 0.12 % | $ 80.1 M | ||
|
Myriad Genetics
MYGN
|
52.3 | $ 4.8 | 1.05 % | $ 444 M | ||
|
NeoGenomics
NEO
|
77.7 | $ 9.44 | 1.94 % | $ 1.21 B | ||
|
Medpace Holdings
MEDP
|
50.4 | $ 417.54 | -0.27 % | $ 12 B | ||
|
National Research Corporation
NRC
|
29.4 | $ 17.41 | 5.77 % | $ 390 M | ||
|
Charles River Laboratories International
CRL
|
65 | $ 165.78 | -0.71 % | $ 8.22 B | ||
|
PRA Health Sciences, Inc.
PRAH
|
98.1 | - | - | $ 10.7 B | ||
|
Enzo Biochem
ENZ
|
50.3 | - | -8.98 % | $ 14.8 K | ||
|
Exact Sciences Corporation
EXAS
|
30.8 | - | - | $ 19.8 B | ||
|
Guardant Health
GH
|
46.1 | $ 87.6 | 0.6 % | $ 11 B | ||
|
Personalis
PSNL
|
55.8 | $ 5.78 | 4.71 % | $ 342 M | ||
|
Motus GI Holdings
MOTS
|
77.2 | - | -34.28 % | $ 263 K | ||
|
Interpace Biosciences
IDXG
|
66.9 | $ 2.12 | 7.07 % | $ 9.38 M | ||
|
Senseonics Holdings
SENS
|
10.3 | $ 5.1 | -22.84 % | $ 213 M | ||
|
Soleno Therapeutics
SLNO
|
27 | $ 52.87 | 0.09 % | $ 2.69 B | ||
|
Thermo Fisher Scientific
TMO
|
70 | $ 469.21 | -2.04 % | $ 177 B | ||
|
QIAGEN N.V.
QGEN
|
30.8 | - | - | $ 10.6 B | ||
|
Twist Bioscience Corporation
TWST
|
44.5 | $ 60.4 | 3.34 % | $ 3.61 B | ||
|
Biomerica
BMRA
|
57.7 | $ 2.19 | 0.46 % | $ 5.03 M | ||
|
Laboratory Corporation of America Holdings
LH
|
52.9 | $ 255.84 | -0.37 % | $ 21.3 B | ||
|
Natera
NTRA
|
81.5 | $ 207.28 | 0.54 % | $ 20.4 B | ||
|
Neogen Corporation
NEOG
|
66.6 | $ 9.53 | 1.38 % | $ 2.07 B | ||
|
Invitae Corporation
NVTA
|
242 | - | - | $ 21.2 M | ||
|
Waters Corporation
WAT
|
306 | $ 307.12 | -0.68 % | $ 18.3 B | ||
|
Quest Diagnostics Incorporated
DGX
|
44.9 | $ 192.67 | -0.79 % | $ 21.4 B |